Measure of Engagement of Epilepsy Patients in Messaging Groups

Not Applicable

Completed

• Conditions: Epilepsy
• Interventions: Behavioral: Facilitator support and education

• Registration Number: NCT03076645
• Lead Sponsor: Royal Free Hospital NHS Foundation Trust

Brief Summary

This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Detailed Description

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management.

Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.

Study Timeline

• Study Start: 2016-10-01
• Study First Submitted: 2017-02-02
• Study First Submitted QC: 2017-03-06
• Study First Posted: 2017-03-10
• Primary Completion: 2017-08-10
• Study Completion: 2017-08-10
• Status Verified: 2017-10
• Last Update Submitted: 2017-10-11
• Last Update Posted: 2017-10-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 202

Inclusion Criteria

• Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application

Exclusion Criteria

• A diagnosis of learning disability/difficulty, significant mental health conditions; those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Experimental	Facilitator support and education	The Experimental Group will be placed in a group using the matching algorithm. Facilitator support and education intervention

Primary Outcome Measures

Name	Time	Method
Engagement	6 weeks	Average participant number of posts over time frame assessed by tracking number of participant entries

Secondary Outcome Measures

Name	Time	Method
Epilepsy medication adherence	Change in Baseline to 6 weeks	Medication adherence based on self-reported questionnaire
Epilepsy self-management	Change in Baseline to 6 weeks	Patient activation measure based on self-reported questionnaire
Epilepsy quality of life	Change in Baseline to 6 weeks	Quality of life in epilepsy metric based on self-reported questionnaire

Trial Locations

Locations (5)

Lewisham & Greenwich NHS Trust; 🇬🇧 Lewisham, United Kingdom

Barts and The London NHS Trust; 🇬🇧 London, United Kingdom

Royal Free Hospital; 🇬🇧 London, United Kingdom

National Hospital for Neurology and Neurosurgery; 🇬🇧 London, United Kingdom

Kent Community Health NHS Trust; 🇬🇧 Maidstone, United Kingdom